7-Chloro-5-(methylthio)-[1,2,4]triazolo[1,5-c]pyrimidine

Catalog No. :
ACAIYU028
CAS No. :
883738-14-5
Molecular Formula :
C6H5ClN4S
Molecular Weight :
200.65

IUPAC Name:7-chloro-5-(methylthio)-[1,2,4]triazolo[1,5-c]pyrimidine

7-Chloro-5-(methylthio)-[1,2,4]triazolo[1,5-c]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$484.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Chloro-5-(methylthio)-[1,2,4]triazolo[1,5-c]pyrimidine
IUPAC Name7-chloro-5-(methylthio)-[1,2,4]triazolo[1,5-c]pyrimidine
MDL No.MFCD18837716
Molecular FormulaC6H5ClN4S
Molecular Weight200.65
SMILESCSC1=NC(Cl)=CC2=NC=NN12
InChI KeyQPWVSBIHNPUZAP-UHFFFAOYSA-N
Synonym7-CHLORO-5-(METHYLTHIO)-[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE(WX130368);7-CHLORO-5-(METHYLTHIO)-[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE;7-Chloro-5-methylsulfanyl-[1,2,4]triazolo[1,5-c]pyrimidine;[1,2,4]Triazolo[1,5-c]pyrimidine, 7-chloro-5-(methylthio)-
CAS No.883738-14-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAIYU028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLXGR190 route compound structure diagram
    ACLXGR19089280-24-0 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACAIYU028 route product structure diagram
    ACAIYU028883738-14-5
Inquiry

2. ACAIYU028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUOHN392 route compound structure diagram
    ACUOHN392883738-16-7 In Stock
  4. Then
  5. ACAIYU028 route product structure diagram
    ACAIYU028883738-14-5
Inquiry

Comments (0)